For the first time, scientists have developed a drug which slows the destruction of the brain in Alzheimer's patients. After decades of failure, the new medicine known as Lecanemab, has been heralded a momentous moment for researchers, as it shows that a new era of drugs to treat the most common form of dementia is possible.
However, the treatment only has a small effect and its impact on people's daily lives has been debated, BBC News reports. The drug also is said to currently only work in the early stages of the disease, so most people would miss out unless there is a medical revolution in spotting the condition sooner.
But after years of disappointment in the search for a treatment, the results of the trial for Lecanemab are being seen as a vital turning point. Alzheimer's Research UK has gone on to call the findings "momentous".
